PlexBio Co., Ltd. (6572.TWO)

TWD 11.3

(-4.24%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 167.17 Million 191.18 Million 124.94 Million 101.34 Million -
Cost of Revenue 104.7 Million 132.19 Million 86.38 Million 59.66 Million -
Gross Profit 62.46 Million 58.99 Million 38.56 Million 41.68 Million -
Operating Expenses 126.62 Million 125.93 Million 173.81 Million 189.99 Million -
Selling, General and Administrative Expenses 63.65 Million 53.32 Million 60.5 Million 76.62 Million -
Research and Development Expenses 62.96 Million 72.6 Million 113.31 Million 113.36 Million -
Other Expenses - 10.96 Million 1.58 Million 3.26 Million -
Cost and Expenses 231.32 Million 258.12 Million 260.2 Million 249.65 Million -
Operating Income -64.15 Million -52.96 Million -131.35 Million -140.83 Million -
Interest Expense 263 Thousand 167 Thousand 226 Thousand 234 Thousand 386 Thousand
Income Tax Expense - - - - -
Earnings before Tax -58.53 Million -53.13 Million -131.58 Million -141.06 Million -
Net Income -58.53 Million -53.13 Million -131.58 Million -141.06 Million -
Earnings Per Share Basic -0.56 -0.51 -1.27 -1.37 -2.32
Earnings Per Share Diluted -0.56 -0.51 -1.27 -1.37 -2.32
Weighted Average Shares Outstanding 103.64 Million 103.64 Million 103.53 Million 103.01 Million 79.86 Million
Weighted Average Shares Outstanding (Diluted) 104.51 Million 103.64 Million 103.53 Million 103.01 Million 79.86 Million
Gross Margin 0.37 0.31 0.31 0.41 -
EBIT Margin -0.24 -0.17 -0.85 -1.14 -
Profit Margin -0.35 -0.28 -1.05 -1.39 -
EBITDA -40.28 Million -32.89 Million -106.81 Million -115.53 Million -148.63 Million
Earnings Before Tax Margin -0.38 -0.28 -1.05 -1.39 -

Income Statement Charts